Ayabe, Tatsuhiro
Shinohara, Masakazu
Kita, Masahiro
Takahashi, Chika
Saito, Jiro
Furuyashiki, Tomoyuki
Toba, Kenji
Umeda, Satoshi
Ano, Yasuhisa
Article History
Received: 1 May 2024
Accepted: 20 September 2024
First Online: 8 October 2024
Declarations
:
: TA, YA, MK, and CT are employees of Kirin Holdings Company Limited, the funder of the study. The funder designed the entire study and supplied the test tablets but had no role in data collection. The authors declare no other conflict of interests.
: The study was conducted in accordance with the Declaration of Helsinki and Ethical Guidelines for Medical and Health Research Involving Human Subjects and was approved by the ethics committee of Ueno Clinic (Tokyo, Japan). Written informed consent was obtained from all subjects. The study was registered in the database of University Hospital Medical Information Network Clinical Trials Registry prior to subject enrollment (registration No. UMIN000037780, registered on 20/12/2020).